{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:15:41Z","timestamp":1790046941408,"version":"4.0.1"},"reference-count":44,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2025.14879","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T12:03:42Z","timestamp":1736251422000},"source":"Crossref","is-referenced-by-count":5,"title":["Clinical utility of quantitative ultrasonography parameters combined with serum cancer antigen 15\u20113, human epidermal growth factor receptor 2 and soluble E\u2011cadherin in diagnosing mass\u2011type breast cancer"],"prefix":"10.3892","volume":"29","author":[{"given":"Keshuo","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Breast Surgery, The Affiliated Hospital of Beihua University, Jilin, Jilin 132011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Vascular Surgery, The Affiliated Hospital of Beihua University, Jilin, Jilin 132011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Pain, Jilin Central Hospital, Jilin, Jilin 132011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Xiu","sequence":"additional","affiliation":[{"name":"Department of Imaging, The Affiliated Hospital of Beihua University, Jilin, Jilin 132011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"key20250207091927_b1-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"20211033","DOI":"10.1259\/bjr.20211033","article-title":"Understanding breast cancer as a global health concern","volume":"95","author":"Wilkinson","year":"2022","journal-title":"Br J Radiol"},{"key":"key20250207091927_b2-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.lpm.2019.09.022","article-title":"Breast cancer epidemiology","volume":"48","author":"Sancho-Garnier","year":"2019","journal-title":"Presse Med"},{"key":"key20250207091927_b3-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40659-017-0140-9","article-title":"Awareness and current knowledge of breast cancer","volume":"50","author":"Akram","year":"2017","journal-title":"Biol Res"},{"key":"key20250207091927_b4-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-3-030-20301-6_4","article-title":"Breast cancer: Current perspectives on the disease status","volume":"1152","author":"Ullah","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"key20250207091927_b5-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"549","DOI":"10.26444\/aaem\/75943","article-title":"Primary and secondary prevention of breast cancer","volume":"24","author":"Kolak","year":"2017","journal-title":"Ann Agric Environ Med"},{"key":"key20250207091927_b6-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"1994764","DOI":"10.1155\/2021\/1994764","article-title":"Review of breast cancer pathologigcal image processing","volume":"2021","author":"Zhang","year":"2021","journal-title":"Biomed Res Int"},{"key":"key20250207091927_b7-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"11728","DOI":"10.3390\/ijms160511728","article-title":"Soy and breast cancer: Focus on angiogenesis","volume":"16","author":"Varinska","year":"2015","journal-title":"Int J Mol Sci"},{"key":"key20250207091927_b8-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"106544","DOI":"10.1016\/j.ijscr.2021.106544","article-title":"Surgical excision of a lactating adenoma with rapid enlargement: A case report","volume":"89","author":"Hara","year":"2021","journal-title":"Int J Surg Case Rep"},{"key":"key20250207091927_b9-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"7035","DOI":"10.12659\/MSM.914395","article-title":"Correlation between doppler ultrasound blood flow parameters and angiogenesis and proliferation activity in breast cancer","volume":"25","author":"Niu","year":"2019","journal-title":"Med Sci Monit"},{"key":"key20250207091927_b10-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.2217\/fon.10.93","article-title":"Color doppler ultrasonography for treatment response prediction and evaluation in breast cancer","volume":"6","author":"Kumar","year":"2010","journal-title":"Future Oncol"},{"key":"key20250207091927_b11-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.2174\/1381612819666131125145517","article-title":"Breast cancer biomarkers: Risk assessment, diagnosis, prognosis, prediction of treatment efficacy and toxicity, and recurrence","volume":"20","author":"Braden","year":"2014","journal-title":"Curr Pharm Des"},{"issue":"(Pt B)","key":"key20250207091927_b12-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1016\/j.ijbiomac.2018.09.020","article-title":"Ultrasensitive immunoassay of tumor protein CA 15.3 in MCF-7 breast cancer cell lysates and unprocessed human plasma using gold nanoparticles doped on the structure of mesoporous silica","volume":"120","author":"Hasanzadeh","year":"2018","journal-title":"Int J Biol Macromol"},{"key":"key20250207091927_b13-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"e0163030","DOI":"10.1371\/journal.pone.0163030","article-title":"CA153 in breast secretions as a potential molecular marker for diagnosing breast cancer: A meta analysis","volume":"11","author":"Tang","year":"2016","journal-title":"PLoS One"},{"key":"key20250207091927_b14-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.7314\/APJCP.2016.17.4.1609","article-title":"HER-2 positive breast cancer-a mini-review","volume":"17","author":"Asif","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20250207091927_b15-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1001\/jama.291.16.1972","article-title":"HER-2 testing in breast cancer using parallel tissue-based methods","volume":"291","author":"Yaziji","year":"2004","journal-title":"JAMA"},{"key":"key20250207091927_b16-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.2741\/4031","article-title":"Soluble E-cadherin: More than a symptom of disease","volume":"17","author":"Grabowska","year":"2012","journal-title":"Front Biosci (Landmark Ed)"},{"key":"key20250207091927_b17-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1002\/ijc.29982","article-title":"Beyond a tumor suppressor: Soluble E-cadherin promotes the progression of cancer","volume":"138","author":"Hu","year":"2016","journal-title":"Int J Cancer"},{"key":"key20250207091927_b18-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3892\/ol.2020.11676","article-title":"Diagnostic value of Doppler ultrasound parameters combined with MMP-11 in early breast cancer and benign breast diseases","volume":"20","author":"Ren","year":"2020","journal-title":"Oncol Lett"},{"key":"key20250207091927_b19-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"e0133830","DOI":"10.1371\/journal.pone.0133830","article-title":"Elevated levels of serum tumor markers CEA and CA15-3 are prognostic parameters for different molecular subtypes of breast cancer","volume":"10","author":"Shao","year":"2015","journal-title":"PLoS One"},{"key":"key20250207091927_b20-ol-29-3-14879","first-page":"29","article-title":"HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients","volume":"14","author":"Zeiwar","year":"2007","journal-title":"Egypt J Immunol"},{"key":"key20250207091927_b21-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/his.14091","article-title":"WHO classification of tumours editorial board. The 2019 World health organization classification of tumours of the breast","volume":"77","author":"Tan","year":"2020","journal-title":"Histopathology"},{"key":"key20250207091927_b22-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"e0261138","DOI":"10.1371\/journal.pone.0261138","article-title":"Correlation of breast cancer microcirculation construction with tumor stem cells (CSCs) and epithelial-mesenchymal transition (EMT) based on contrast-enhanced ultrasound (CEUS)","volume":"16","author":"Leng","year":"2021","journal-title":"PLoS One"},{"key":"key20250207091927_b23-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"5200","DOI":"10.1002\/jcp.26379","article-title":"Breast cancer diagnosis: Imaging techniques and biochemical markers","volume":"233","author":"Jafari","year":"2018","journal-title":"J Cell Physiol"},{"key":"key20250207091927_b24-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/bcr3114","article-title":"Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: A prospective observational study","volume":"14","author":"Bidard","year":"2012","journal-title":"Breast Cancer Res"},{"key":"key20250207091927_b25-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"645","DOI":"10.17219\/acem\/26301","article-title":"Ultrasound elastography-review of techniques and its clinical applications","volume":"23","author":"Zaleska-Dorobisz","year":"2014","journal-title":"Adv Clin Exp Med"},{"key":"key20250207091927_b26-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"157","DOI":"10.7326\/M14-0692","article-title":"Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts","volume":"162","author":"Sprague","year":"2015","journal-title":"Ann Intern Med"},{"key":"key20250207091927_b27-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/0284185114524197","article-title":"Quantitative MRI morphology of invasive breast cancer: Correlation with immunohistochemical biomarkers and subtypes","volume":"56","author":"Bae","year":"2015","journal-title":"Acta Radiol"},{"key":"key20250207091927_b28-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3109\/1354750X.2013.840800","article-title":"The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment","volume":"18","author":"Li","year":"2013","journal-title":"Biomarkers"},{"key":"key20250207091927_b29-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/cam4.1859","article-title":"Elevated serum HER-2 predicts poor prognosis in breast cancer and is correlated to ADAM10 expression","volume":"8","author":"Zheng","year":"2019","journal-title":"Cancer Med"},{"key":"key20250207091927_b30-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/bjc.2016.427","article-title":"Soluble VE-cadherin in metastatic breast cancer: An independent prognostic factor for both progression-free survival and overall survival","volume":"116","author":"Rochefort","year":"2017","journal-title":"Br J Cancer"},{"key":"key20250207091927_b31-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10549-013-2695-7","article-title":"Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers","volume":"141","author":"Lee","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"(4A)","key":"key20250207091927_b32-ol-29-3-14879","first-page":"1963","article-title":"Importance of CEA and CA 15-3 during disease progression in metastatic breast cancer patients","volume":"27","author":"Laessig","year":"2007","journal-title":"Anticancer Res"},{"key":"key20250207091927_b33-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s13277-011-0180-7","article-title":"Kinetics of CEA and CA15-3 correlate with treatment response in patients undergoing chemotherapy for metastatic breast cancer (MBC)","volume":"32","author":"Di Gioia","year":"2011","journal-title":"Tumour Biol"},{"key":"key20250207091927_b34-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"103684","DOI":"10.1016\/j.ebiom.2021.103684","article-title":"Decoding the molecular subtypes of breast cancer seen on multimodal ultrasound images using an assembled convolutional neural network model: A prospective and multicentre study","volume":"74","author":"Zhou","year":"2021","journal-title":"EBioMedicine"},{"key":"key20250207091927_b35-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"9S","DOI":"10.2967\/jnumed.115.157834","article-title":"Clinical diagnosis and management of breast cancer","volume":"57","author":"McDonald","year":"2016","journal-title":"J Nucl Med"},{"key":"key20250207091927_b36-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.3892\/etm.2020.8868","article-title":"Clinical value of color Doppler ultrasound combined with serum CA153, CEA and TSGF detection in the diagnosis of breast cancer","volume":"20","author":"Song","year":"2020","journal-title":"Exp Ther Med"},{"key":"key20250207091927_b37-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s12291-012-0288-6","article-title":"Diagnostic significance of CA15-3 with combination of HER-2\/neu values at 85th percentiles in breast cancer","volume":"28","author":"Thriveni","year":"2013","journal-title":"Indian J Clin Biochem"},{"key":"key20250207091927_b38-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/mc.22048","article-title":"Soluble-E-cadherin activates HER and IAP family members in HER2+ and TNBC human breast cancers","volume":"53","author":"Brouxhon","year":"2014","journal-title":"Mol Carcinog"},{"key":"key20250207091927_b39-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.mjafi.2022.01.015","article-title":"Role of qualitative contrast-enhanced ultrasound in the diagnosis of malignant breast lesions","volume":"79","author":"Grewal","year":"2023","journal-title":"Med J Armed Forces India"},{"key":"key20250207091927_b40-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.2147\/OTT.S124134","article-title":"Diagnostic and prognostic values of contrast-enhanced ultrasound in breast cancer: A retrospective study","volume":"10","author":"Zhao","year":"2017","journal-title":"Onco Targets Ther"},{"key":"key20250207091927_b41-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"1035645","DOI":"10.3389\/fonc.2023.1035645","article-title":"A nomogram based on combining clinical features and contrast enhanced ultrasound is not able to identify Her-2 over-expressing cancer from other breast cancers","volume":"13","author":"Lin","year":"2023","journal-title":"Front Oncol"},{"key":"key20250207091927_b42-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.critrevonc.2010.12.005","article-title":"Current technologies for HER2 testing in breast cancer","volume":"80","author":"Moelans","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20250207091927_b43-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1080\/1061186X.2023.2245579","article-title":"Emerging targeted therapeutic strategies for the treatment of triple-negative breast cancer","volume":"31","author":"Kumari","year":"2023","journal-title":"J Drug Target"},{"key":"key20250207091927_b44-ol-29-3-14879","doi-asserted-by":"publisher","first-page":"153","DOI":"10.25122\/jml-2022-0189","article-title":"Features of VEGF and IL-6 expression in patients with inflammatory breast cancer considering molecular-biological characteristics","volume":"16","author":"Smolanka","year":"2023","journal-title":"J Med Life"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T07:19:33Z","timestamp":1738912773000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2025.14879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,1,7]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2025.14879","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"article-number":"133"}}